Treatment of Lip Sores
For herpes labialis (cold sores), initiate oral antiviral therapy with either valaciclovir 2g twice daily for 1 day or famciclovir 1500mg as a single dose at the first sign of symptoms for optimal outcomes. 1
Determining the Cause
First, identify whether this is herpes labialis versus another etiology:
Herpes labialis characteristics:
- Prodrome of itching, burning, or tingling before visible lesions
- Progression through vesicle → pustule → ulcer → crust stages
- Peak viral replication occurs within first 24 hours of lesion onset
- Common triggers: UV light exposure, fever, stress, menstruation 1
Alternative causes to consider:
- Bacterial infection (S. aureus): presents with swelling, warmth, possible abscess formation, particularly in immunocompromised patients 2
- Actinic cheilitis: chronic sun damage, requires different management 3
- Other inflammatory or neoplastic conditions 4, 5, 6
Treatment Algorithm for Herpes Labialis
Timing is Critical
Treatment must begin within 24 hours of symptom onset - ideally at the prodrome stage - as viral replication peaks early and natural healing begins within the first day. Delayed treatment significantly reduces efficacy 1.
First-Line Treatment: Oral Antivirals
Preferred regimens (FDA-approved):
- Valaciclovir: 2g twice daily for 1 day (reduces episode duration by approximately 1 day) 1
- Famciclovir: 1500mg single dose (significantly reduces healing time, p<0.001 vs placebo) 1
- Aciclovir: 400mg five times daily for 5 days (less convenient but effective) 1
Why oral over topical: Oral antivirals are superior to topical agents as they achieve systemic drug levels, block viral replication more effectively, and reduce outbreak duration and pain by approximately 1 day compared to placebo 1. Topical antivirals provide only small clinical benefit and require multiple daily applications (4-5 times daily for 5 days) 1.
Safety Profile
All three oral antivirals (aciclovir, valaciclovir, famciclovir) are well-tolerated with minimal adverse events. Headache is most common (<10%), with nausea occurring in <4% of patients. No serious adverse events reported in clinical trials 1.
For Frequent or Severe Recurrences
Suppressive therapy indications:
- Frequent outbreaks (≥6 per year)
- Severe, prolonged, or disfiguring episodes
- Immunocompromised patients 1
Suppressive regimens:
- Valaciclovir 500mg once daily for 4 months (significantly extends time to recurrence: 13.1 vs 9.6 weeks, p=0.016) 1
- Aciclovir 400mg twice daily for 4 months 1
Adjunctive Measures
Prevention strategies:
- Sunscreen or zinc oxide application to lips before UV exposure 1
- Avoid known personal triggers
Symptomatic relief:
- OTC topical anesthetics, analgesics (limited evidence but may provide comfort) 1
- Avoid topical corticosteroids alone (experimental aciclovir/hydrocortisone combinations show benefit but require 5-6 applications daily) 1
If Not Herpes Labialis
For bacterial infection (S. aureus):
- Requires culture to identify organism and antibiotic sensitivities
- Treatment: IV followed by oral antibiotics (consider MRSA coverage)
- Surgical drainage if abscess present
- Average hospital stay 4 days for severe cases 2
For other causes: Diagnosis-specific management required based on clinical presentation, imaging, and potentially biopsy 4, 5, 6.
Critical Pitfalls to Avoid
- Delayed treatment: Waiting beyond 24 hours significantly reduces antiviral efficacy
- Using topical antivirals alone: These are inferior to oral agents for treatment (though oral agents are prescription-only in most countries) 1
- Confusing herpes labialis with bacterial infection: Bacterial infections require antibiotics, not antivirals, and may need surgical intervention 2
- Assuming self-limiting course means no treatment needed: While true for some patients, those with painful, frequent, or disfiguring outbreaks benefit significantly from antiviral therapy 1